mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |